Daily Healthcare St. Lucia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Daily Healthcare St. Lucia.

Press releases published on August 31, 2026

10 hours ago

Arch Biopartners Receives Central IRB Approval to Support U.S. Sites in Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial of LSALT Peptide

Indeterminate GlobeNewswire

10 hours ago

Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

10 hours ago

Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

10 hours ago

Sofwave Announces Publication of Data from Randomized Controlled Study of its Pure Impact™ VIP Platform Utilizing PlyoPulse™ EMS Technology in Aesthetic Surgery Journal

Indeterminate GlobeNewswire

10 hours ago

OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

10 hours ago

Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia

Indeterminate GlobeNewswire

10 hours ago

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

Indeterminate GlobeNewswire

10 hours ago

AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference

Indeterminate GlobeNewswire

10 hours ago

BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Indeterminate GlobeNewswire

10 hours ago

Revelyx Bio Launches to Advance YY003, an Investigational Recombinant Botulinum Toxin Type A in a Ready-to-Use Liquid Formulation

Indeterminate GlobeNewswire

10 hours ago

ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib

Indeterminate GlobeNewswire

10 hours ago

Teladoc Health Appoints Michael Grasher as Chief Financial Officer

Indeterminate GlobeNewswire

10 hours ago

Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference

Indeterminate GlobeNewswire

10 hours ago

Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions

Indeterminate GlobeNewswire

10 hours ago

Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray

Indeterminate GlobeNewswire

10 hours ago

Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day

Indeterminate GlobeNewswire

11 hours ago

NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

11 hours ago

SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers

Indeterminate GlobeNewswire

11 hours ago

Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire

11 hours ago

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

Indeterminate GlobeNewswire